Literature DB >> 985447

Altered polyamine metabolism in the PRO/Re strain of inbred mice.

C A Manen, R L Blake, D H Russell.   

Abstract

The PRO/Re strain of inbred mice are characterized by abnormally high concentrations of proline in both blood (hyperprolinaemia) and urine (prolinuria). They excrete increased amounts of polyamines in their urine. Male PRO/Re mice excreted putrescine at 175% and spermidine at 300% the amount of male C57BL/6J controls. Female PRO/Re mice excreted putrescine at 115% and spermidine at 150% of the amount in the urine of female controls. Examination of the enzymes involved in polyamine biosynthesis revealed that ornithine decarboxylase, the initial enzyme in the polyamine-biosynthetic pathway, was increased by 150% in the kidneys and by 100% in the liver of male PRO/Re mice. There was no significant difference between PRO/Re and C57BL/6J male mice for either putrescine- or spermidine-stimulated S-adenosylmethionine decarboxylase activity. Female PRO/Re mice showed no significant difference from female C57BL/6J mice for any of the enzymes examined. When the concentrations of the polyamines in the tissues of the PRO/Re mice were determined, spermidine and spermine concentrations in the kidneys of the male PRO/Re mice were twice those of the controls. Spermidine concentration in the livers of both male and female PRO/Re mice was approx. 130% that of the controls. Polyamine concentrations in the brains were similar in controls and mutants. The increased polyamine biosynthesis and excretion in the PRO/Re mutant mice may be a mechanism to decrease the extent of proline accumulation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 985447      PMCID: PMC1164006          DOI: 10.1042/bj1580529

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  FAMILIAL HYPERPROLINEMIA. REPORT OF A SECOND CASE, ASSOCIATED WITH CONGENITAL RENAL MALFORMATIONS, HEREDITARY HEMATURIA AND MILD MENTAL RETARDATION, WITH DEMONSTRATION OF AN ENZYME DEFECT.

Authors:  M L EFRON
Journal:  N Engl J Med       Date:  1965-06-17       Impact factor: 91.245

2.  The pharmacology of spermine and spermidine; distribution and excretion.

Authors:  S M ROSENTHAL; C W TABOR
Journal:  J Pharmacol Exp Ther       Date:  1956-02       Impact factor: 4.030

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Measurement of putrescine, spermidine, and spermine in physiological fluids by use of an amino acid analyzer.

Authors:  L J Marton; D H Russell; C C Levy
Journal:  Clin Chem       Date:  1973-08       Impact factor: 8.327

5.  Polyamine depletion of the MTW9 mammary tumor and subsequent elevation of spermidine in the sera of tumor-bearing rats as a biochemical marker of tumor regression.

Authors:  D H Russell; P M Gullino; L J Marton; S M LeGendre
Journal:  Cancer Res       Date:  1974-09       Impact factor: 12.701

6.  [Sex-specific differences in the free amino acids in adult urine (author's transl)].

Authors:  N Liappis
Journal:  Z Klin Chem Klin Biochem       Date:  1973-07

7.  Studies on the biosynthetic pathway of polyamines in rat liver.

Authors:  J Jänne
Journal:  Acta Physiol Scand Suppl       Date:  1967

8.  The selective in vivo incorporation and metabolism of radioactive putrescine in the adult male rat.

Authors:  R B Clark; W R Fair
Journal:  J Nucl Med       Date:  1975-05       Impact factor: 10.057

9.  Relative usefulness of measuring polyamines in serum, plasma, and urine as biochemical markers of cancer.

Authors:  D H Russell; S D Russell
Journal:  Clin Chem       Date:  1975-06       Impact factor: 8.327

10.  Polyamines as predictors of success and failure in cancer chemotherapy.

Authors:  D H Russell; B G Durie; S E Salmon
Journal:  Lancet       Date:  1975-10-25       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.